Detalles de la búsqueda
1.
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile.
Int J Mol Sci
; 25(3)2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339198
2.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging
; 50(3): 892-907, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334104
3.
Side-Chain Modified [99mTc]Tc-DT1 Mimics: A Comparative Study in NTS1R-Positive Models.
Int J Mol Sci
; 24(21)2023 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958525
4.
[68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results.
Int J Mol Sci
; 23(23)2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36498918
5.
Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach.
Eur J Nucl Med Mol Imaging
; 47(12): 2856-2865, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32291511
6.
[99mTc]Tc-DGA1, a Promising CCK2R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography.
Mol Pharm
; 17(8): 3116-3128, 2020 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568549
7.
Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
Int J Mol Sci
; 21(21)2020 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33114537
8.
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
Molecules
; 25(15)2020 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32731473
9.
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu-DOTAGA-PEG2 -RM26.
Int J Cancer
; 145(12): 3347-3358, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077356
10.
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability.
J Labelled Comp Radiopharm
; 62(10): 646-655, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963606
11.
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
Molecules
; 24(6)2019 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871262
12.
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
Bioconjug Chem
; 29(5): 1774-1784, 2018 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29664606
13.
Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand.
Inorg Chem
; 56(14): 8175-8186, 2017 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28657295
14.
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
Molecules
; 22(11)2017 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137110
15.
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT.
Eur J Nucl Med Mol Imaging
; 43(5): 964-973, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26631238
16.
Improved Quantification of the Beta Cell Mass after Pancreas Visualization with 99mTc-demobesin-4 and Beta Cell Imaging with 111In-exendin-3 in Rodents.
Mol Pharm
; 13(10): 3478-3483, 2016 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27537699
17.
Theranostic approaches in nuclear oncology: From bench to bed.
J Labelled Comp Radiopharm
; 62(10): 612-614, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325329
18.
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.
Pharmaceutics
; 16(4)2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675174
19.
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
EJNMMI Radiopharm Chem
; 9(1): 13, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366299
20.
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability.
Pharmaceutics
; 16(3)2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543286